할랄 의약품 시장(2026-2030년)

The global halal pharmaceuticals market is forecasted to grow by USD 11512.7 mn during 2025-2030, accelerating at a CAGR of 7.4% during the forecast period. The report on the global halal pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding demographics and increasing consumer preference for sharia-compliant , harmonization of halal certification standards and proactive government mandates, technological innovations in gelatin substitutes and advanced bio-based material sourcing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global halal pharmaceuticals market is segmented as below:

By Product Type

• Prescription medicines
• Over the counter medicines
• Vaccines
• Biopharmaceuticals

By Formulation

• Tablets and capsules
• Liquid formulations
• Injectables
• Topical formulations

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

Geography

• APAC
  • Indonesia
  • China
  • Pakistan
  • Bangladesh
  • India
  • Malaysia
• Middle East and Africa
  • Turkey
  • Iran
  • Egypt
  • UAE
• North America
  • US
  • Canada
  • Mexico
• Europe
  • Russia
  • Germany
  • UK
  • France
  • Italy
  • Spain
• South America
  • Brazil
  • Argentina
  • Colombia
• Rest of World (ROW)

This study identifies the integration of halal compliance into cdmo workflows as one of the prime reasons driving the global halal pharmaceuticals market growth during the next few years. Also, strategic expansion of halal active pharmaceutical ingredient and institutional adoption of halal biopharmaceuticals and vaccines will lead to sizable demand in the market.

The report on the global halal pharmaceuticals market covers the following areas:

• Global halal pharmaceuticals market sizing
• Global halal pharmaceuticals market forecast
• Global halal pharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global halal pharmaceuticals market vendors that include Abbott Laboratories, Ain Medicare Sdn Bhd, Beximco Pharmaceuticals Ltd., Bosch Pharmaceuticals Pvt Ltd., CKD OTTO Pharma, Daewoong Infion, Dexa Group, Duopharma Biotech Berhad, Fresenius Kabi AG, Gulf Pharmaceutical Inds., Hikma Pharmaceuticals Plc, Incepta Pharmaceuticals Ltd., Kimia Farma Tbk, Pharmaniaga Berhad, PT Bio Farma, PT Kalbe Farma Tbk, PT PIM Pharmaceuticals, Simpor Pharma Sdn Bhd, Square Pharmaceuticals PLC, Tabuk Pharmaceuticals. Also, the global halal pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Halal Pharmaceuticals Market 2020 - 2024
  • Historic Market Size - Data Table on Global Halal Pharmaceuticals Market 2020 - 2024 ($ million)
• 5.2 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.3 Formulation segment analysis 2020 - 2024
  • Historic Market Size - Formulation Segment 2020 - 2024 ($ million)
• 5.4 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI Global Halal Pharmaceuticals Market
• 6.2 Impact of Geopolitical Conflicts on Global Halal Pharmaceuticals Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product Type

• 8.1 Market segments
• 8.2 Comparison by Product Type
• 8.3 Prescription medicines - Market size and forecast 2025-2030
• 8.4 Over the counter medicines - Market size and forecast 2025-2030
• 8.5 Vaccines - Market size and forecast 2025-2030
• 8.6 Biopharmaceuticals - Market size and forecast 2025-2030
• 8.7 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

9 Market Segmentation by Formulation

• 9.1 Market segments
• 9.2 Comparison by Formulation
• 9.3 Tablets and capsules - Market size and forecast 2025-2030
• 9.4 Liquid formulations - Market size and forecast 2025-2030
• 9.5 Injectables - Market size and forecast 2025-2030
• 9.6 Topical formulations - Market size and forecast 2025-2030
• 9.7 Market opportunity by Formulation
  • Market opportunity by Formulation ($ million)

10 Market Segmentation by Distribution Channel

• 10.1 Market segments
• 10.2 Comparison by Distribution Channel
• 10.3 Retail pharmacies - Market size and forecast 2025-2030
• 10.4 Hospital pharmacies - Market size and forecast 2025-2030
• 10.5 Online pharmacies - Market size and forecast 2025-2030
• 10.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 APAC - Market size and forecast 2025-2030
  • 12.3.1 Indonesia - Market size and forecast 2025-2030
  • 12.3.2 China - Market size and forecast 2025-2030
  • 12.3.3 Pakistan - Market size and forecast 2025-2030
  • 12.3.4 Bangladesh - Market size and forecast 2025-2030
  • 12.3.5 India - Market size and forecast 2025-2030
  • 12.3.6 Malaysia - Market size and forecast 2025-2030
• 12.4 Middle East and Africa - Market size and forecast 2025-2030
  • 12.4.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.4.2 Turkey - Market size and forecast 2025-2030
  • 12.4.3 Iran - Market size and forecast 2025-2030
  • 12.4.4 Egypt - Market size and forecast 2025-2030
  • 12.4.5 UAE - Market size and forecast 2025-2030
• 12.5 North America - Market size and forecast 2025-2030
  • 12.5.1 US - Market size and forecast 2025-2030
  • 12.5.2 Canada - Market size and forecast 2025-2030
  • 12.5.3 Mexico - Market size and forecast 2025-2030
• 12.6 Europe - Market size and forecast 2025-2030
  • 12.6.1 Russia - Market size and forecast 2025-2030
  • 12.6.2 Germany - Market size and forecast 2025-2030
  • 12.6.3 UK - Market size and forecast 2025-2030
  • 12.6.4 France - Market size and forecast 2025-2030
  • 12.6.5 Italy - Market size and forecast 2025-2030
  • 12.6.6 Spain - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Colombia - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expanding demographics and increasing consumer preference for sharia-compliant
  • Harmonization of halal certification standards and proactive government mandates
  • Technological innovations in gelatin substitutes and advanced bio-based material sourcing
• 13.2 Market challenges
  • Fragmentation of international halal certification frameworks and regulatory ambiguity
  • Substantial capital requirements for dedicated production infrastructure
  • Supply chain bottlenecks and limited availability of halal-certified active pharmaceutical ingredients
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of halal compliance into CDMO workflows
  • Strategic expansion of halal active pharmaceutical ingredient
  • Institutional adoption of halal biopharmaceuticals and vaccines

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Ain Medicare Sdn Bhd
  • Ain Medicare Sdn Bhd - Overview
  • Ain Medicare Sdn Bhd - Product / Service
  • Ain Medicare Sdn Bhd - Key offerings
  • SWOT
• 15.6 Bosch Pharmaceuticals Pvt Ltd.
  • Bosch Pharmaceuticals Pvt Ltd. - Overview
  • Bosch Pharmaceuticals Pvt Ltd. - Product / Service
  • Bosch Pharmaceuticals Pvt Ltd. - Key offerings
  • SWOT
• 15.7 CKD OTTO Pharma
  • CKD OTTO Pharma - Overview
  • CKD OTTO Pharma - Product / Service
  • CKD OTTO Pharma - Key offerings
  • SWOT
• 15.8 Daewoong Infion
  • Daewoong Infion - Overview
  • Daewoong Infion - Product / Service
  • Daewoong Infion - Key offerings
  • SWOT
• 15.9 Dexa Group
  • Dexa Group - Overview
  • Dexa Group - Product / Service
  • Dexa Group - Key offerings
  • SWOT
• 15.10 Duopharma Biotech Berhad
  • Duopharma Biotech Berhad - Overview
  • Duopharma Biotech Berhad - Product / Service
  • Duopharma Biotech Berhad - Key offerings
  • SWOT
• 15.11 Fresenius Kabi AG
  • Fresenius Kabi AG - Overview
  • Fresenius Kabi AG - Product / Service
  • Fresenius Kabi AG - Key offerings
  • SWOT
• 15.12 Gulf Pharmaceutical Inds.
  • Gulf Pharmaceutical Inds. - Overview
  • Gulf Pharmaceutical Inds. - Product / Service
  • Gulf Pharmaceutical Inds. - Key offerings
  • SWOT
• 15.13 Kimia Farma Tbk
  • Kimia Farma Tbk - Overview
  • Kimia Farma Tbk - Product / Service
  • Kimia Farma Tbk - Key offerings
  • SWOT
• 15.14 Pharmaniaga Berhad
  • Pharmaniaga Berhad - Overview
  • Pharmaniaga Berhad - Product / Service
  • Pharmaniaga Berhad - Key offerings
  • SWOT
• 15.15 PT Bio Farma
  • PT Bio Farma - Overview
  • PT Bio Farma - Product / Service
  • PT Bio Farma - Key offerings
  • SWOT
• 15.16 PT Kalbe Farma Tbk
  • PT Kalbe Farma Tbk - Overview
  • PT Kalbe Farma Tbk - Product / Service
  • PT Kalbe Farma Tbk - Key offerings
  • SWOT
• 15.17 PT PIM Pharmaceuticals
  • PT PIM Pharmaceuticals - Overview
  • PT PIM Pharmaceuticals - Product / Service
  • PT PIM Pharmaceuticals - Key offerings
  • SWOT
• 15.18 Simpor Pharma Sdn Bhd
  • Simpor Pharma Sdn Bhd - Overview
  • Simpor Pharma Sdn Bhd - Product / Service
  • Simpor Pharma Sdn Bhd - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations